Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiometabolic Dysregulation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11276 Neoplasms 9021 Carcinoma, Non-Small-Cell Lung 5852 Prostatic Neoplasms 5426 Colorectal Neoplasms 5071 Lung Neoplasms 4337 Pancreatic Neoplasms 3065 Multiple Myeloma 3063 Neoplasm Metastasis 3015 Leukemia, Myeloid, Acute 3001 Carcinoma, Hepatocellular 2797 Ovarian Neoplasms 2724 Melanoma 2696 Stomach Neoplasms 2621 Lymphoma 2560 Head and Neck Neoplasms 2220 Recurrence 2175 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2126 Leukemia 2052 Brain Neoplasms 2021 Colonic Neoplasms 1977 Lymphoma, Non-Hodgkin 1939 Rectal Neoplasms 1889 Uterine Cervical Neoplasms 1847 Glioblastoma 1736 Leukemia, Lymphocytic, Chronic, B-Cell 1704 Carcinoma, Renal Cell 1645 Squamous Cell Carcinoma of Head and Neck 1594 Lymphoma, Follicular 1559 Esophageal Neoplasms 1545

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04021446 2021-09-29

ASCEND

University of Southern California

Phase NA Withdrawn

Cardiometabolic Dysregulation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡